Abstract
Selenium may have a protective effect against mercury toxicity. The aim of the present study was to investigate if selenium excretion in urine was affected in persons with dental amalgam fillings. The reason for this study is that dental amalgam is the most important source of inorganic mercury exposure in the general population, although the potential toxic effects of this exposure remain a subject for debate.
The chelating agent 2,3 dimercaptopropane-1-sulfonate (DMPS) was injected intravenously (2 mg/kg) to provoke metal excretion. Urine samples were subsequently collected at intervals over a 24-h period. Selenium concentration was determined by hydride-generation atomic absorption spectrometry. The study was comprised of 20 persons who claimed symptoms from dental amalgam and 21 healthy persons with amalgam fillings. There were two control groups without amalgam. One control group had amalgam replaced because of concern about illness resulting from mercury release (n=20), whereas the other control group never had amalgam (n=19).
Individuals with amalgam excreted less selenium (36.4 µg, median value) over 24 hours than those without amalgam (47.5 µg) (p=0.016). There was no difference in selenium excretion between groups with (42.4 µg) and without (39.4 µg) amalgam-related symptoms (p=0.15).
The findings indicate that individuals exposed to low levels of elemental mercury from dental amalgam excrete less selenium to urine than unexposed individuals.
Similar content being viewed by others
References
F. L. Lorscheider, M. J. Vimy, and A. O. Summers, Mercury exposure from silver tooth fillings—emerging evidence questions a traditional paradigm, FASEB J. 9, 504–508 (1995).
J. R. Mackert and A. Berglund, Mercury exposure from dental amalgam fillings: absorbed dose and the potential for adverse health effects, Crit. Rev. Oral Biol. Med. 8, 410–436 (1997).
U. F. Malt, P. Nerdrum, B. Oppedal, R. Gundersen, M. Holte, and J. Löne, Physical and mental problems attributed to dental amalgam fillings: a descriptive study of 99 self-referred patients compared with 272 controls, Psychosom. Med. 59, 32–41 (1997).
D. Melchart, E. Wühr, W. Weidenhammer, and L. Kremers, A multicenter survey of amalgam fillings and subjective complaints in non-selected patients in the dental practice, Eur. J. Oral Sci. 106, 770–777 (1998).
S. Stenman and L. Grans, Symptoms and differential diagnosis of patients fearing mercury toxicity from amalgam fillings, Scand. J. Work Environ. Health 23(Suppl. 3), 59–63 (1997).
M. Ahlqwist, C. Bengtsson, B. Furunes, L. Hollender, and L. Lapidus, Number of amalgam tooth fillings in relation to subjectively experienced symptoms in a study of Swedish women, Community Dent. Oral Epidemiol. 16, 227–231 (1988).
Department of Health and Human Services, Dental Amalgam: A Scientific Review and Recommended Public Health Service Strategy for Research, Education and Regulation, Department of Health and Human Services. Public Health Service, Washington, DC, (1993).
Health Canada, The Safety of Dental Amalgam, Health Canada, Ottawa, Canada (1996).
P. D. Whanger, Selenium in the treatment of heavy metal poisoning and chemical carcinogenesis, J. Trace Element Electrolytes Health Dis. 6, 209–221 (1992).
P. D. Whanger, Selenium and heavy metal toxicity, in Selenium in Biology and Medicine, J. E. Spallholz, J. L. Martin, and H. E. Ganther, eds., AVI, Westport, CT, pp. 230–255 (1981).
D. G. Ellingsen, Y. Thomassen, J. Aaseth, and J. Alexander, Cadmium and selenium in blood and urine related to smoking habits and previous exposure to mercury vapour, J. Appl. Toxicol. 17, 337–343 (1997).
G. Drasch, E. Wanghofer, G. Roider, and S. Strobach, Correlation of mercury and selenium in the human kidney, J. Trace Elements Med. Biol. 10, 251–254 (1996).
D. V. Frost, Selenium and vitamin E as antidotes to heavy metal toxicities, in Selenium in Biology and Medicine, J. E., Spallholz, ed., AVI, Westport, CT, pp. 490–498 (1981).
J. Parizek and I. Ostadalova, The protective effect of small amounts of selenite in sublimate intoxication, Experientia 23, 142–143 (1967).
A. Naganuma and N. Imura, Changes in distribution of mercury and selenium in soluble fractions of rabbit tissues after simultaneous administration, Pharmacol. Biochem. Behav. 13, 537–544 (1980).
M. L. A. Cuvin-Aralar and R. W. Furness, Mercury and selenium interaction: a review, Ecotoxicol. Environ. Safety 21, 348–364 (1991).
K. T. Suzuki, C. Sasakura, and S. Yoneda, Binding sites for the (Hg-Se) complex on selenoprotein P, Biochim. Biophys. Acta 1429, 102–112 (1998).
L. Hagmar, M. Persson-Moschos, B. Akesson, and A. Schütz, Plasma levels of selenium, selenoprotein P and glutathione peroxidase and their correlations to fish intake and serum levels of thyrotropin and thyroid hormones: a study on Latvian fish consumers, Eur. J. Clin. Nutr. 52, 796–800 (1998).
H. M. Meltzer, K. Bibow, I. T. Paulsen, H. H. Mundal, G. Norheim, and H. Holm, Different bioavailability in humans of wheat and fish selenium as measured by blood-platelet response to increased dietary Se, Biol. Trace Element Res. 36, 229–241 (1993).
C. Sasakura and K. T. Suzuki, Biological interaction between transition metals (Ag, Cd and Hg), selenide/sulfide and selenoprotein P, J. Inorg. Biochem. 71, 159–162 (1998).
Y. Xia, X. Zhao, L. Zhu, and P. D. Whanger, Metabolism of selenate and selenomethionine by a selenium-deficient poulation of men in China, J. Nutr. Biochem. 3, 202–210 (1992).
T. W. Clarkson, The toxicology of mercury, Crit. Rev. Clin. Lab. Sci. 34, 369–403 (1997).
J. C. Hansen, Has selenium a beneficial role in human exposure to inorganic mercury? Med. Hypotheses 25, 45–53 (1988).
G. N. Schrauzer, Quecksilber-Selen-Wechselwirkungen und das Zahnamalgam-Problem, in Status Quo and Perspectives of Amalgam and Other Dental Materials, L. T. Friberg and G. N. Schrauzer, eds., Thieme, Stuttgart, pp. 106–118 (1995).
G. Drasch, S. Mailander, and C. Schlosser, Content of non-mercury-associated selenium in human tissues, Biol. Trace Element Res. 77, 219–230 (2000).
I. Falnoga, M. Tusek-Znidaric, M. Horvat, and P. Stegnar, Mercury, selenium, and cadmium in human autopsy samples from Idrija residents and mercury mine workers, Environ. Res. 84, 211–218 (2000).
B. M. Eley, A study of mercury redistribution, excretion and renal pathology in guineapigs implanted with powdered dental amalgam for between 2 and 4 years, J. Exp. Pathol. (Oxford) 71, 375–393 (1990).
B. M. Eley and S. W. Cox, Influence of a standard laboratory diet containing nutritionally adequate levels of selenium on renal pathology from mercury released by experimental amalgam tattoos, Biomaterials 9, 339–344 (1988).
J. Robinson, M. Robinson, O. Levander, and C. Thomson, Urinary excretion of selenium by New Zealand and North American human subjects on differing intakes, Am. J. Clin. Nutr. 41, 1023–1031 (1985).
M. Janghorbani, M. J. Christensen, A. Nahapetian, and V. R. Young, Selenium metabolism in healthy adults: quantitative aspects using the stable isotope 74SeO3(2−), Am. J. Clin. Nutr. 35, 647–654 (1982).
J. M. G. Lafuente, M. L. F. Sanchez, and A. SanzMedel, Speciation of inorganic selenium and selenoaminoacids by on-line reversed-phase high-performance liquid chromatography focused microwave digestion hydride generation atomic detection, J. Anal. Atomic Spectrom. 11, 1163–1169 (1996).
B. Gammelgaard, K. D. Jessen, F. H. Kristensen, and O. Jøns, Determination of trimethylselenonium ion in urine by ion chromatography and inductively coupled plasma mass spectrometry detection, Anal. Chim. Acta 404, 47–54 (2000).
A. J. Blotcky, J. P. Claassen, E. P. Rack, and D. M. Shoop, Evaluation of methods for separation of trimethylselenonium ion as a major, minor or general metabolite using neutron-activation analysis, J. Radioanal. Nucl. Chem. 181, 395–400 (1994).
A. T. Nahapetian, V. R. Young, and M. Janghorbani, Measurement of trimethylselenonium ion in human urine, Anal. Biochem. 140, 56–62 (1984).
J. S. Vamnes, R. Eide, R. Isrenn, P. J. Høl, and N. R. Gjerdet, Diagnostic value of DMPS in patients with symptoms allegedly caused by amalgam fillings, J. Dent. Res. 79, 868–874 (2000).
A. Alegria, R. Barbera, R. Farre, E. Ferrer, M. J. Lagarda, and M. A. Torres, Optimization of selenium determination in human milk and whole blood by flow injection hydride atomic absorption spectrometry, J. AOAC Int. 81, 457–461 (1998).
L. Björkman, G. Sandborgh-Englund, and J. Ekstrand, Mercury in saliva and feces after removal of amalgam fillings, Toxicol. Appl. Pharmacol. 144, 156–162 (1997).
G. B. Lygre, P. J. Høl, R. Eide, R. Isrenn, and N. R. Gjerdet, Mercury and silver in saliva from subjects with symptoms self-related to amalgam fillings, Clin. Oral Invest. 3, 216–218 (1999).
D. G. Ellingsen, H. P. Nordhagen, and Y. Thomassen, Urinary selenium excretion in workers with low exposure to mercury-vapor, J. Appl. Toxicol. 15, 33–36 (1995).
D. G. Ellingsen, R. I. Holland, Y. Thomassen, M. Landro-Olstad, W. Frech, and H. Kjuus, Mercury and selenium in workers previosly exposed to mercury-vapor at a chloralkali plant, Br. J. Ind. Med. 50, 745–752 (1993).
L. Barregård, Y. Thomassen, A. Schütz, and S. L. Marklund, Levels of selenium and antioxidative enzymes following occupational exposure to inorganic mercury, Sci. Total Environ. 99, 37–47 (1990).
K. M. Hurlbut, R. M. Maiorino, M. Mayersohn, R. C. Dart, D. C. Bruce, and H. V. Aposhian, Determination and metabolism of dithiol chelating-agents XVI: pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers, J. Pharmacol. Exp. Ther. 268, 662–668 (1994).
P. J. Høl, J. S. Vamnes, N. R. Gjerdet, R. Eide, and R. Isrenn, Dental amalgam and selenium in blood, Environ. Res. 87, 141–146 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Høl, P.J., Vamnes, J.S., Gjerdet, N.R. et al. Dental amalgam affects urinary selenium excretion. Biol Trace Elem Res 85, 137–147 (2002). https://doi.org/10.1385/BTER:85:2:137
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:85:2:137